Neurohypophysial Disorders Flashcards

1
Q

Name the two main groups of hypothalamic nuclei which terminate in the neurohypophysis?

A

Paraventricular Nucleus Supraoptic Nucleus NOTE: nucleus = group of cell bodies in CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What two hormones are produced by the neurohypophysis?

A

Vasopressin Oxytocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the principal action of vasopressin and how does it carry out this action?

A

Vasopressin = ADH (anti-diuretic hormone) Vasopressin’s main action is on the V2 receptors in the renal cortical and medullary collecting ducts cells which are impermeable to water It stimulates aquaporin 2 synthesis and the ones which are stored inside vesicles to be inserted into the apical membrane (facing lumen) This increases water reabsorption by making the collecting duct cells permeable to water and has an antidiuretic effect NOTE: diuresis = increase in urine production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is diabetes insipidus?

A

A disease which causes production of large volumes of dilute urine (polyuria) and excessive thirst (polydipsia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the two forms of diabetes insipidus?

A

Cranial (central) = absence or lack of circulating vasopressin Nephrogenic = end-organ (kidneys) resistance to vasopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can cause cranial diabetes insipidus?

A

ACQUIRED (more common) - by damage to the neurohypophysial system, e.g. by: Traumatic brain injury Pituitary surgery Pituitary tumours, craniopharyngioma (benign tumours which grow just above the pituitary gland near the base of the brain - they affect the pituitary gland as they grow so close to it) Metastasis to the pituitary gland (e.g breast cancer) Granulomatous infiltration of median eminence eg TB, sarcoidosis - i.e. spread of infection to the median eminence resulting in a granuloma (mass of macrophages and other immune cells - formed in inflammatory response) CONGENITAL (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What can cause nephrogenic diabetes insipidus?

A

Congenital (rare) - e.g: mutation in gene encoding V2 receptor so the receptor doesn’t respond to vasopressin → MAIN mutation in aquaporin 2 so it isn’t embedded into the collecting duct basolateral membrane properly Acquired - by drug use, e.g: lithium - accumulates in collecting duct cells and interfere with cell response to vasopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

State some signs and symptoms of diabetes insipidus.

A

Polyuria - large volumes of urine production Hypo-osmolar urine - very dilute Polydipsia - excessive thirst and drinking Dehydration (and consequences) if fluid intake not maintained - can lead to DEATH Possible disruption of sleep due to nocturia Possible electrolyte imbalance if dehydration occurs leading to hyper-osmolar plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State another cause of polydipsia that isn’t diabetes.

A

Psychogenic polydipsia This is a central disturbance so is most commonly seen in psychiatric patients that increases the drive to drink - the exact cause (aetiology) for this is unclear Anticholineregic drugs can be used in psychiatry - this can lead to a ‘dry mouth’ which also stimulates the feeling of a need to drink This psychiatric effect can also be seen in patients who are told to ‘drink plenty’ by healthcare professions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What test can be used to distinguish between normal, psychogenic polydipsia, central DI and nephrogenic DI? Describe the results you would expect.

A

Fluid deprivation test: Normal and psychogenic polydipsia will show a rise in urine osmolality (more concentrated urine being produced over time and in lower amounts) Central and nephrogenic diabetes insipidus will show little or no change in urine osmolality (and volume) Fluid deprivation with administration of DDAVP (Desmopressin) = vasopressin substitute: Central diabetes insipidus will show a rise in urine osmolality (lower volumes of more concentrated urine produced) Nephrogenic DI will still have a low urine osmolality (and volume) because of end-organ resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is the urine osmolality of someone with psychogenic polydipsia lower (mainly in the fluid deprivation test) than a normal subject?

A

Because there is a constant passage of large volumes of water through the kidneys, this will reduce the osmotic gradient which is necessary for vasopressin to have its effect, resulting in slightly less water reabsorption, therefore slightly lower urine osmolality (more dilute urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the normal change in urine osmolality as plasma osmolality increases. How does this differ in DI?

A

Normally, urine osmolality will increase as plasma osmolality increases - due to increased water reabsorption and production of concentrated urine to maintain plasma osmolality In DI, there is little change in urine osmolality as plasma osmolality increases - still large volumes of dilute urine being produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is SIADH?

A

Syndrome of Inappropriate ADH When the plasma vasopressin concentration is inappropriately high for the existing plasma osmolality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the symptoms of SIADH?

A

Can be symptomless However if p[Na+] <120 mM: generalised weakness, poor mental function, nausea If p[Na+] <110 mM: CONFUSION leading to COMA and ultimately DEATH Hyponatreamia causes problems with neural transmission (AP generation requires Na+ influx) - the extent of the hyponatreamia determines the symptoms (i.e. extent of neurological disruption)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

State some causes of SIADH.

A

CNS SAH, stroke, tumour, TBI Pulmonary disease Pneumonia, bronchiectasis Malignancy Lung (small cell) Drug-related Carbamazepine, SSRI Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is SIADH treated?

A

Fluid Restriction Provide appropriate treatment when the cause is identified (e.g. surgery for a tumour) NOTE: if someone is hyponatraemic you need to deal with that as soon as possible – e.g. use drugs that prevent vasopressin action in the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

State two selective vasopressin receptor peptidergic agonists.

A

V1 selective – Terlipressin V2 selective - Desmopressin (used to treat CRANIAL diabetes insipidus to reduce unwanted effects by acting on other vasopressin receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

State one treatment used for nephrogenic diabetes insipidus and its possible mechanism of action.

A

Thiazides (e.g. bendroflumethiazide) This inhibits the Na+/Cl- pump in the DCT leading to a diuretic effect - reduced Na+ reabsorption → reduced water reabsorption The reduced Na+ and water reabsorption leads to ECF volume depletion This results in a compensatory increase in Na+ reabsorption from the PCT This increases proximal water reabsorption so less water reaches the collecting duct This ultimately leads to reduced urine volume

19
Q

What are vaptans?

A

Non-peptide vasopressin receptor antagonists Tolvaptan = V2 receptor antagonist It is used to treat hyponatraemia associated with SIADH and may be useful in treating congestive heart failure

20
Q

State some drugs that increase or decrease vasopressin secretion.

A

Increase vasopressin secretion = nicotine Decrease vasopressin secretion = alcohol + glucocorticoids

21
Q

What does the posterior pituitary look like on a pituitary MRI?

A

It is seen as a ‘bright spot’ - small white shape NOTE: it is not always seen on an MRI scan but that doesn’t mean that it’s not there

22
Q

Describe the hypothalamus-neurohypophysial system.

A

The posterior pituitary (neurohypophysis) is made up of neural tissue (nerve axons) These posterior pituitary axons have their cell bodies in the hypothalamus So essentially neurones originating in the hypothalamic nuclei terminate in the posterior pituitary These neurones secrete neurosecretions (hormones) into the bloodstream from the neurohypophysis where they terminate NOTE: some neurones from the paraventricular nucleus terminates in the median eminence so neurosecretions can have an effect on the anterior pituitary (e.g. TRH stimulates TSH secretion)

23
Q

What is the main way in which vasopressin release is regulated?

A

There are osmoreceptors located in the organum vasculosum (circumventricular organs = don’t have BBB - capillary endothelial cells do not have such tight junctions between them)

24
Q

Describe the structure of osmoreceptors.

A

Osmoreceptors are neurones which terminate project to the paraventricular and supraoptic nuclei to stimulate/inhibit their neurosecretions of vasopressin

25
Q

Explain how osmoreceptors work.

A

Osmoreceptors are very sensitive to changes in extracellular osmolality When extracellular osmolality increases (due to increase in extracullar Na+ conc) then water moves out of the osmoreceptors and they shrink There are mechanosensitive ion channels embedded into the osmoreceptor membranes which detect this and stimulate increased osmoreceptor firing (increased APs)

26
Q

Define osmolality.

A

The total number of solute particles per KILOGRAM of solvent - measures concentration of a solution

27
Q

Explain the difference between osmolality and osmolarity.

A

Both osmolarity and osmolality are measures of the concentration of a solution - the higher the figure, the more concentrated the solution However, osmolarity measures the total number of solute particles per LITRE of solution Because osmolarity is taking into account volume, it can be affected by changes in temperature or pressure

28
Q

What does increased osmoreceptor firing result in?

A

Increased stimulation by the osmoreceptors of the paraventricular and supraoptic to release vasopressin This leads to increased water reabsorption from renal collecting ducts which results in: reduced urine volume, increased urine osmolality reduced plasma osmolality ALSO increase osmoreceptor firing stimulates thirst which also has the effect of reducing plasma osmolality

29
Q

Why is dehydration so dangerous?

A

It can cause an increase in electrolyte concentration which can affect nervous transmission/APs → can cause sudden abnormal electrical activity in the brain = seizures It can also lead to decreased blood volume → hypovolaemic shock = tissue perfusion insufficient to meet metabolic requirements (hypotension) → lack of brain perfusion → death

30
Q

Explain what happens in a patient with diabetes insipidus.

A

Inadequate production of/response to vasopressin Large volumes of dilute (hypotonic) urine produced Increase in plasma osmolality (incl. increase in Na+ conc) Reduction in ECF (includes plasma and IF) volume - due to decrease in blood volume Reduced ECF volume detected by osmoreceptors stimulating thirst and drinking Leads to increased ECF volume again (increased plasma volume means plasma osmolarity maintained)

31
Q

What happens when a patient with diabetes insipidus has no access to water?

A

They become dehydrated and die because drinking is the only thing which is allowing them to maintain their ECF volume and plasma osmolarity - this is essential to preventing hypovolaemic shock which is the main cause of death

32
Q

What are the symptoms of psychogenic polydipsia?

A

Similar symptoms to DI: polydipsia = excessive drinking/fluid intake polyuria = high urine output BUT unlike DI, ability to secrete vasopressin in response to osmotic stimuli is preserved

33
Q

Explain what happens in a patient with psychogenic polydipsia

A

Increased drinking (polydipsia) Increase in ECF (includes plasma and IF) volume - plasma osmolality reduced due to increase in plasma volume Increase in extracellular osmolality is detected by osmoreceptors which reduce vasopressin secretion Large volumes of dilute (hypotonic) urine produced - due to decreased water reabsorption

34
Q

What is the normal (hydrated) range of plasma osmolality?

A

270-290mOsm/kg H20

35
Q

What is the plasma osmolality in a patient with diabetes insipidus?

A

Slightly above the normal range (above 290) Urine output > drinking input (slightly greater than) Urine output too high due to problem with VP secretion or effect at end-organ

36
Q

What is the plasma osmolality in a patient with psychogenic polydipsia?

A

Slightly below the normal range (below 270) Urine output < drinking input (slightly less than) Drinking too high due to psychiatric (mental) problem

37
Q

At what point would you stop the fluid deprivation test?

A

When the patient has lost more than 3% of their body weight - i.e. they are clinically dehydrated

38
Q

What are the biochemical features of diabetes insipidus?

A

Increased plasma osmolality (especially if fluid intake is restricted) Hypernatraemia - due to higher than normal plasma osmolality Raised urea?? Dilute (hypo-osmolar) urine - i.e. low urine osmolality

39
Q

What are the biochemical features of psychogenic polydipsia?

A

Low plasma osmolality – due to the excess water intake but mild (not too low) as most of this water is being excreted out as urine anyway Mild hyponatraemia – due to low plasma osmolality Dilute (hypo-osmolar) urine - i.e. low urine osmolality

40
Q

What will happen if you give a patient with cranial DI exogenous vasopressin?

A

All their vasopressin receptors will be activated V1: Vascular smooth muscle → vasoconstriction Non-vascular smooth muscle?? - send another email Anterior pituitary → ACTH secretion Liver → glycogenolysis Platelets → factor VIII production CNS → behavioural and other effects V2: Collecting duct cells → water reabsorption - WHAT WE WANT Endothelial cells → vWF production

41
Q

How is desmopressin administered?

A

Nasally - most common Orally Subcutaneously

42
Q

What do patients given desmopressin need to be careful about?

A

Patient needs to make sure NOT to continue drinking large amounts of fluid (like they are used to) – risk of hyponatraemia EXPLANATION: The desmopressin will cause water reabsorption regardless of plasma osmolarity/ECF volume because the desmopressin release is not being regulated by osmoreceptors

43
Q

Explain what happens in a patient with SIADH

A

Increased vasopressin → increased water reabsorption from renal collecting ducts (here: increased = excessive) This causes expansion of ECF (includes plasma and IF) volume Too much water reabsorption leads to HYPONATREAMIA (plasma osmolality low due to increased plasma volume for the same amount of Na+) Increased ECF volume (specifically blood volume) → atrial natriuretic peptide (ANP) release from right atrium ANP causes natriuresis (increased renal Na+ excretion) The purpose of the natriuresis by ANP is to restore euvolaemia (state of normal fluid volume) - because renal Na+ excretion → renal water excretion by osmosis However you still have hyponatraemia because you excreted both Na+ and water meaning you have the same proportions of both before the ANP took effect (state of hyponatreamia)

44
Q

What are the (biochemical) signs of SIADH?

A

Increased urine osmolality, decreased urine volume (initially until ANP starts taking effect which increases urine volume) Decreased p[Na+] (HYPONATRAEMIA) mainly due to increased water reabsorption initially NOTE: p[Na+] = plasma sodium concentration